N-Ethylmaleimide Sensitive Factor (NSF) as a therapeutic target in PM
We study the function and underlying mechanisms of NSF in PM, as well as its potential as a therapeutic target.
Targeting DNA damage response (DDR) pathways to improve the anti-tumor efficacy of chemo- and immunotherapy.
We explore how DDR dysregulation contributes to PM development and how targeting the DDR machinery can improve anti-PM treatments.
